Using recently updated guidelines to evaluate and manage @entity4977 is discussed. @entity301 ( @entity301 ) is a costly chronic condition associated with significant morbidity and mortality. Epidemiologic data further indicate that @entity2299 and @entity558 , which may lead to @entity301 , are grossly undertreated. In 2001, the third National @entity165 Education Program (NCEP) Adult Treatment Panel (ATP III) released updated guidelines for the evaluation and treatment of @entity4977 . Significant changes to the updated guidelines include designation of a @entity301 risk equivalent category identifying @entity1 who require aggressive management, recommendation of Framingham-based @entity301 risk assessment in @entity1 with multiple risk factors, revised target levels for several of the lipids and lipoproteins, and criteria for the identification of @entity1 with the @entity209 . Low-density lipoprotein @entity165 (LDL-C) continues to be the primary target of therapy. In addition, non-high-density lipoprotein @entity165 (HDL-C) is now defined as a secondary treatment target in @entity1 with @entity2298 . Increased emphasis is placed on the @entity209 , low HDL-C levels, and the presence of multiple and emerging risk factors in guiding the intensity of therapy. The NCEP ATP III guidelines acknowledge challenges in implementing and maintaining @entity1 adherence to both lifestyle changes and pharmacotherapy regimens and provide strategies for increasing treatment success. Implementation of these new guidelines will likely enhance identification, management, and treatment success rates among @entity1 at risk for @entity301 in the United States.

Role of the National XXXX Education Program Adult treatment panel III guidelines in managing @entity2299 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity2298 :: ('MESH:D015228', 'Disease') :: ['hypertriglyceridemia'] @entity558 :: ('MESH:C536528', 'Disease') :: ['associated conditions'] @entity2299 :: ('MESH:D050171', 'Disease') :: ['dyslipidemia'] @entity301 :: ('MESH:D003327', 'Disease') :: ['CHD', 'Coronary heart disease'] @entity4977 :: ('MESH:D052439', 'Disease') :: ['lipid disorders'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic syndrome'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['Cholesterol', 'cholesterol']
@entity165 :: (MESH:D002784,Chemical) :: ['Cholesterol']
